IMR Press / RCM / Volume 25 / Issue 4 / DOI: 10.31083/j.rcm2504114
Open Access Review
Clinical Application of Extracorporeal Membrane Oxygenation in the Treatment of Fulminant Myocarditis
Show Less
1 The First Clinical Medical College, Guangdong Medical University, 524002 Zhanjiang, Guangdong, China
2 Department of Anesthesiology, Zhongshan City People’s Hospital, 528403 Zhongshan, Guangdong, China
*Correspondence: liaoxiaozu@163.com (Xiaozu Liao)
Rev. Cardiovasc. Med. 2024, 25(4), 114; https://doi.org/10.31083/j.rcm2504114
Submitted: 23 September 2023 | Revised: 21 October 2023 | Accepted: 25 October 2023 | Published: 26 March 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Fulminant myocarditis (FM) is a rare but serious clinical syndrome which can be characterized by the rapid deterioration of cardiac function, with cardiogenic shock (CS) and arrhythmic electrical storms being common presentations, often requiring adjunctive support with mechanical circulatory devices. With the development of mechanical circulatory support (MCS) devices, there are now more and more studies investigating the application of MCS in FM patients, and the use of extracorporeal membrane oxygenation (ECMO) to treat FM has shown good survival rates. This review elucidates the treatment of FM, and the application and clinical outcomes associated with ECMO intervention.

Keywords
extracorporeal membrane oxygenation
mechanical circulatory support
fulminant myocarditis
myocarditis
cardiogenic shock
Figures
Fig. 1.
Share
Back to top